All Pharma News
Flagship-founded Axcella folds

Flagship-founded Axcella folds
Gabrielle Masson FIERCE BIOTECH
05 Dec 2023
Share Share
Axcella Announces Reverse Stock Split Effective September 19, 2023

Axcella Announces Reverse Stock Split Effective September 19, 2023
BUSINESSWIRE
14 Sep 2023
Share Share
Axcella Granted Patent for Long COVID Fatigue Treatment

Axcella Granted Patent for Long COVID Fatigue Treatment
BUSINESSWIRE
29 Aug 2023
Share Share
Axcella Reports Second Quarter Financial Results and Provides Business Update

Axcella Reports Second Quarter Financial Results and Provides Business Update
BUSINESSWIRE
03 Aug 2023
Share Share
Axcella Reports First Quarter Financial Results and Provides Business Update

Axcella Reports First Quarter Financial Results and Provides Business Update
BUSINESSWIRE
04 May 2023
Share Share
Axcella Reports 4Q and Full Reports Full 2022 FYR and Provides Business Update

Axcella Reports 4Q and Full Reports Full 2022 FYR and Provides Business Update
BUSINESSWIRE
30 Mar 2023
Share Share
Axcella Announces FDA IND Clearance Supporting Path to Registration of AXA1125

Axcella Announces FDA IND Clearance Supporting Path to Registration of AXA1125
BUSINESSWIRE
15 Feb 2023
Share Share
Axcella seeks `light speed` swing at long Covid, but needs cash

Axcella seeks `light speed` swing at long Covid, but needs cash
Lei Lei Wu ENDPTS
24 Jan 2023
Share Share
Axcella Announces Regulatory Path to Registration of AXA1125 for COVID Fatigue

Axcella Announces Regulatory Path to Registration of AXA1125 for COVID Fatigue
James Waldron BUSINESSWIRE
24 Jan 2023
Share Share
Axcella reduces workforce by 85%, prioritizes long Covid drug research

Axcella reduces workforce by 85%, prioritizes long Covid drug research
Katherine Lewin ENDPTS
16 Dec 2022
Share Share